217.9K XNAS Volume
XNAS 22 Apr, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for iRhythm Technologies Inc is on 02 May 2025 for the purpose of iRhythm Technologies Inc First Quarter Earnings Results for 2025
See details
iRhythm Technologies Inc Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
10Positive11Negative
47.6% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
iRhythm Technologies Inc Stock Price Analysis
Day Price Range | 99.5 (LTP) 97.4101.7 LowHigh |
Week Price Range | 99.5 (LTP) 97.2104.1 LowHigh |
Month Price Range | 99.5 (LTP) 92.5110.4 LowHigh |
52 Week Price Range | 99.5 (LTP) 55.9128.5 LowHigh |
iRhythm Technologies Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
iRhythm Technologies Inc's Revenue was higher than average estimate 3 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 48.2% in FY25
Consensus Recommendation
13 ANALYST Recommendations
BUY
The consensus recommendation from 13 analysts for iRhythm Technologies Inc is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get iRhythm Technologies Inc Stock Analysis
iRhythm Technologies Inc stock analysis with key metrics, changes, and trends.
iRhythm Technologies Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $591.84 M | 20.13% | positive |
| |
Annual Net Profit | $113.29 M | 8.2% | positive |
| |
Price to Earning Ratio | -28.03 | - | negative |
| |
Stock Price | $99.48 | -11.25% | negative |
| |
Quarterly Revenue | $164.32 M | 24.01% | positive |
| |
Quarterly Net profit | $1.33 M | 96.56% | positive |
| |
Debt to Equity Ratio | 8.11 | - | negative |
| |
Return on Equity(ROE) | -75.27 % | -75.27% | negative |
| |
Mutual Fund Holding | 93.78 % | 2.39% | positive |
| |
Promoter Share Holding | 1.70 % | 0.38% | positive |
| |
Interest Coverage Ratio | -7.79 | - | negative |
| |
Institutional Holding | 114.79 % | 0.06% | positive |
|
Loading data..
iRhythm Technologies Inc - Company Profile
What does iRhythm Technologies Inc do?

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
iRhythm Technologies Inc Management structure
All Gross Remunerations are in USD